BridgeMD
New treatment option for Thyroid Associated Ophthalmopathy
Official title Multi-model Image of Doxycycline in TAO
ClinicalTrials.gov ID: NCT05112211
What this study is testing
What is Doxycycline Hyclate?
Doxycycline Hyclate is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for thyroid associated ophthalmopathy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Informed consent
- Age 18-70 years old
- Diagnosed with TAO
You likely can't join if
- Sight-threatening TAO with dysthyroid optic neuropathy
- Allergy of tetracycline
- Have contraindications of MRI(metal pacemaker, fake teeth, foreign body and other materials which will disturb the examination)
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.